| Description | Recombinant protein from the full-length sequence of homo sapiens apolipoprotein C3 (APOC3) (NM_000040), with a His tag. |
| Host | Human cells |
| RefSeq Link | NM_000040; NP_000031; UniProt#: P02656; GeneID: 345; |
| Synonyms | APOCIII; HALP2 |
| Molecular Weight | 8.7 kDa |
| Purity | >90% by SDS-PAGE gel and Coomassie Blue staining |
| Applications | Antigens, Western, ELISA and other in vitro binding or in vivo functional assays, and protein-protein interaction studies; For research & development use only! |
| Formulation | Purified protein formulated in a sterile solution of PBS buffer, pH7.2, without any preservatives |
| Endotoxin | >Endotoxin level is < 0.1 ng/µg of protein (<1EU/µg) |
| Background | Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. [provided by RefSeq, Jul 2008]. |
There's no citations at this moment.
There's no FAQs at this moment.
There's no reviews at this moment.